Back to All NewsHOPO Therapeutics completes California Life Sciences FAST Program

HOPO Therapeutics completes California Life Sciences FAST Program

Jun 22, 2022
The team-focused advising program provided frequent mentoring from experts in a range of regulatory, business development and technical fields Learn about FAST
California Life Sciences
FAST Advisory Program: Intensive 12-Week Advisory Program for Early-Stage Life Sciences Startups
More News & Publications
HOPO Therapeutics awarded BARDA contract of up to $226 million
Oct 3, 2024
HOPO Therapeutics awarded BARDA contract of up to $226 million
HOPO Therapeutics jointly awarded $1.78M ARPA-E Grant
Nov 2, 2023
HOPO Therapeutics jointly awarded $1.78M ARPA-E Grant
Jun 9, 2023
Phase 1 Clinical Trial of HOPO 14-1 Now Recruiting
See all news
Stay up to date with research and development updates, news, and more on our mailing list.
HOPO Therapeutics
About UsScienceProgramsNews & PublicationsContact
5858 Horton St. Suite 393 
 Emeryville CA, 94608
info@hopotx.com
+1 (510) 239-3180
A Subsidiary of HOPO Technologies Group
© 2025 HOPO Therapeutics, Inc. All Rights Reserved.
TermsPrivacyDisclaimers